Chronic Severe Neutropenia Associated With Intravenous Immunoglobulin for Multifocal Motor Neuropathy
Open Access
Abstract
Intravenous immunoglobulin (IVIG) is an immunomodulatory therapy derived from pooled donor immunoglobulins and used for treatment of various autoimmune conditions. Here we report the diagnosis and management of IVIG‐induced chronic severe neutropenia with absolute neutrophil count 3/µL in a patient with multifocal motor neuropathy. Serial blood count showed a cyclical pattern of neutropenia: worsening 24–48 h post‐IVIG, then gradually improving before the next infusion. IVIG‐induced neutropenia is rare, with previous reports of predominantly mild transient neutropenia. Our case describes chronic severe neutropenia that developed years after starting IVIG. We summarize available evidence and management strategies for IVIG‐associated neutropenia.Keywords
This publication has 12 references indexed in Scilit:
- Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committeeMuscle & Nerve, 2023
- Neutropenia following intravenous immunoglobulin therapy in adult patients with immune thrombocytopenic purpuraMedicine, 2020
- Multifocal motor neuropathyCurrent Opinion in Neurology, 2018
- Adverse Effects of Immunoglobulin TherapyFrontiers in Immunology, 2018
- Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfactionTherapeutic Advances in Neurological Disorders, 2014
- Adverse Effects of Human Immunoglobulin TherapyTransfusion Medicine Reviews, 2013
- Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study)Journal of the Peripheral Nervous System, 2013
- Neutropenia Following IVIG Therapy in Pediatric Patients With Immune-Mediated ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 2005
- Neutropenia as a Complication of High-Dose Intravenous Immunoglobulin Therapy in Adult Patients With Neuroimmunologic DisordersClinical Neuropharmacology, 2003
- Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarmingInternational Journal of Immunopharmacology, 1999